![N-(3-fluoro-4-(2-(1-methyl-1H-imidazol-4-yl)thieno[3,2-b]pyridin-7-yloxy)phenylcarbamothioyl)-2-phenylacetamide structure, CAS 875337-44-3](/structures/180000/170455_2_875337_44_3.png)
| Chemical & Physical Properties | |
|---|---|
| CAS Number | 875337-44-3 |
| Catalog No. | 2A-1170305 |
| Chinese Name | N-(3-氟-4-(2-(1-甲基-1H-咪唑-4-基)噻吩并[3,2-B]吡啶-7-氧基)苯基氨基硫代甲酰基)-2-苯乙酰胺 |
| Synonyms | cc-38; MGCD-265; S1361_Selleck; MGCD265,MGCD-265; MGCD-265 analog |
| Molecular Formula | C26H20FN5O2S2 |
| Molecular Weight | 517.598 |
| Density | 1.4±0.1 g/cm3 |
| Boiling Point | 195.7ºC at 760 mmHg |
| Appearance | powder |
| Storage Condition | -20℃ |
| Application | MGCD265-analog is structurally similar to MGCD-265. MGCD265-analog is a potent multi-target tyrosine kinase inhibitor that acts on c-Met and VEGFR2 with IC50 values of 29 nM and 10 nM respectively. |
| PubChem ID | 53786494 |
| SMILES | Cn1cnc(-c2cc3nccc(Oc4ccc(NC(=S)NC(=O)Cc5ccccc5)cc4F)c3s2)c1 |
| InChI | InChI=1S/C26H20FN5O2S2/c1-32-14-20(29-15-32)23-13-19-25(36-23)22(9-10-28-19)34-21-8-7-17(12-18(21)27)30-26(35)31-24(33)11-16-5-3-2-4-6-16/h2-10,12-15H,11H2,1H3,(H2,30,31,33,35) |
| InChI Key | UFICVEHDQUKCEA-UHFFFAOYSA-N |
| Transport Info | Product name: MGCD-265 |
Phone:
630-322-8886
630-322-8887
Email:
Office Locations:
Chicago, IL, USA
San Francisco, CA, USA